Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2a3a767ae32dfcda1f4e6642aeadc9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-177 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-6615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate |
2016-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6584855a3ede8d87814ccab395d74523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50980f67caac3eeae79e88923f79bf7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be9d8bdbe7e74e4e9e970464bb6f225f |
publicationDate |
2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3386994-A1 |
titleOfInvention |
4,6-di-(o-thiophosphate)-inositol-1,2,3,5-tetra-o-sulfate for c. difficile infection |
abstract |
The present invention relates to inositol bisthiophosphates-tetrakissulfates, particularly for use in treating symptoms associated with Clostridium difficile infection. |
priorityDate |
2015-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |